ALX Oncology Announces Upcoming Virtual Investor Conference Participation
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage...
Year: 2021
Mountain Valley MD Holdings Completes Licensing Agreement With Red White and Bloom Brands Inc.
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)...
Resonant to Report Third Quarter 2021 Financial Results on Wednesday, November 10th at 3:30 P.M. Central Time
AUSTIN, Texas, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions...
HMNC Brain Health to Participate in Microdose’s Wonderland: Miami Conference on November 8-9, 2021
MUNICH, Germany, Nov. 02, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company...
Maravai LifeSciences Announces November 2021 Investor Conference Schedule
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents...
ChemoCentryx to Hold Third Quarter 2021 Financial Results Conference Call on Tuesday, November 9, 2021
MOUNTAIN VIEW, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter...
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
– Mr. Johnson brings broad commercial expertise with over 30 years of leadership spanning dermatology marketing, sales, sales management, digital...
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
SUZHOU, China and PALO ALTO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global...
CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9
BERKELEY HEIGHTS, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Atreca Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
SAN CARLOS, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on...
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Highlights: Revenue of $167.3 million up 15% year-over-year. Excluding revenue from divested businesses, revenue increased 27% year-over-yearDiluted GAAP earnings per...
Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia
Addition of Bi-Functional Protein Is Complementary to Lead Asset QRX003 for Netherton SyndromeASHBURN, Va., Nov. 02, 2021 (GLOBE NEWSWIRE) --...
Assure Holdings Joins MultiPlan PPO Network
DENVER, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider...
scPharmaceuticals to Present at the Jefferies London Healthcare Conference
BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Part of Psychedelic Medicine Research Renaissance
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) today...
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing...
Achieve Life Sciences Announces FDA Acceptance of IND Application for Cytisinicline’s Second Planned Indication for Nicotine E-cigarette Cessation
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a...
Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Rheumatoid Arthritis
Phase 1 trial is underway with topline results expected in the first half of 2022 Represents Landos’ seventh IND cleared...
ECAM Council 2nd edition ‘Finding New Ways to Care’ brought in high profile global leaders to Rome
An Urgent Call to Support Healthcare Investment in Public-Private Initiatives Delegates at the second edition of ECAM – The European...
Akoya Biosciences Announces Founding Members of First-of-its-Kind Imaging Innovators (I²) Network
CODEX Brain Tissue Image CODEX staining of a human brain tissue sample reveals the presence of biomarkers that enable researchers...
